![]() |
![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NALCN-AS1 intron | CTD | PMID:30157460 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of NALCN-AS1 intron | CTD | PMID:30157460 | |
PubMed | 20889312 |
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NR_047687 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
GenBank Nucleotide | AEKP01041322 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AK025806 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL137879 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL138707 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL139374 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL356732 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL359085 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL391841 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
KF455817 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
KF455820 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NR_047687 | ||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
CTCGCAAGACCTGGTTGTTTAAAAGTGGGCGGCACCTTCCCCTTCGCTCTTCCTCCTGCTCCTGhide sequence |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NR_047687.1(NALCN-AS1):n.141+62154G>T | single nucleotide variant | Lung cancer [RCV000097595] | Chr13:100802782 [GRCh38] Chr13:101455036 [GRCh37] Chr13:13q32.3 |
uncertain significance |
GRCh38/hg38 13q12.11-34(chr13:19833130-114298614)x3 | copy number gain | See cases [RCV000134104] | Chr13:19833130..114298614 [GRCh38] Chr13:20407270..115064089 [GRCh37] Chr13:19305270..114082191 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q32.2-33.1(chr13:98008015-103697232)x3 | copy number gain | See cases [RCV000133986] | Chr13:98008015..103697232 [GRCh38] Chr13:98660269..104349582 [GRCh37] Chr13:97458270..103147583 [NCBI36] Chr13:13q32.2-33.1 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18445862-114327173)x1 | copy number loss | See cases [RCV000135610] | Chr13:18445862..114327173 [GRCh38] Chr13:19020001..115085141 [GRCh37] Chr13:10098739..114110750 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q31.2-34(chr13:88937651-114327173)x3 | copy number gain | See cases [RCV000137102] | Chr13:88937651..114327173 [GRCh38] Chr13:89589905..115085141 [GRCh37] Chr13:88387906..114110750 [NCBI36] Chr13:13q31.2-34 |
pathogenic |
GRCh38/hg38 13q31.3-33.3(chr13:93345058-109458154)x1 | copy number loss | See cases [RCV000136688] | Chr13:93345058..109458154 [GRCh38] Chr13:93997311..110110501 [GRCh37] Chr13:92795312..108908502 [NCBI36] Chr13:13q31.3-33.3 |
pathogenic |
GRCh38/hg38 13q32.1-33.3(chr13:97213871-109162916)x1 | copy number loss | See cases [RCV000138024] | Chr13:97213871..109162916 [GRCh38] Chr13:97866125..109815264 [GRCh37] Chr13:96664126..108613265 [NCBI36] Chr13:13q32.1-33.3 |
pathogenic |
GRCh38/hg38 13q14.11-34(chr13:40942298-114340331)x1 | copy number loss | See cases [RCV000137893] | Chr13:40942298..114340331 [GRCh38] Chr13:41516434..115085141 [GRCh37] Chr13:40414434..114123908 [NCBI36] Chr13:13q14.11-34 |
pathogenic |
GRCh38/hg38 13q31.1-34(chr13:78999318-114327106)x3 | copy number gain | See cases [RCV000138742] | Chr13:78999318..114327106 [GRCh38] Chr13:79573453..115085141 [GRCh37] Chr13:78471454..114110683 [NCBI36] Chr13:13q31.1-34 |
pathogenic |
GRCh38/hg38 13q31.1-34(chr13:86788927-114340331)x1 | copy number loss | See cases [RCV000138340] | Chr13:86788927..114340331 [GRCh38] Chr13:87441182..115085141 [GRCh37] Chr13:86239183..114123908 [NCBI36] Chr13:13q31.1-34 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19833130-114327106)x3 | copy number gain | See cases [RCV000139078] | Chr13:19833130..114327106 [GRCh38] Chr13:20407270..115085141 [GRCh37] Chr13:19305270..114110683 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q32.1-34(chr13:95744855-110863818)x3 | copy number gain | See cases [RCV000139021] | Chr13:95744855..110863818 [GRCh38] Chr13:96397109..111516165 [GRCh37] Chr13:95195110..110314166 [NCBI36] Chr13:13q32.1-34 |
pathogenic |
GRCh38/hg38 13q32.1-34(chr13:96745059-114327106)x3 | copy number gain | See cases [RCV000139160] | Chr13:96745059..114327106 [GRCh38] Chr13:97397313..115085141 [GRCh37] Chr13:96195314..114110683 [NCBI36] Chr13:13q32.1-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18456040-114340285)x3 | copy number gain | See cases [RCV000140004] | Chr13:18456040..114340285 [GRCh38] Chr13:19030180..115105760 [GRCh37] Chr13:17928180..114123862 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q31.1-34(chr13:78964223-114340331)x3 | copy number gain | See cases [RCV000141248] | Chr13:78964223..114340331 [GRCh38] Chr13:79538358..115085141 [GRCh37] Chr13:78436359..114123908 [NCBI36] Chr13:13q31.1-34 |
pathogenic |
GRCh38/hg38 13q31.1-34(chr13:83288131-114342258)x3 | copy number gain | See cases [RCV000141804] | Chr13:83288131..114342258 [GRCh38] Chr13:83862266..115107733 [GRCh37] Chr13:82760267..114125835 [NCBI36] Chr13:13q31.1-34 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19671934-114340331)x3 | copy number gain | See cases [RCV000142924] | Chr13:19671934..114340331 [GRCh38] Chr13:20246074..115085141 [GRCh37] Chr13:19144074..114123908 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18862146-114342258)x3 | copy number gain | See cases [RCV000143462] | Chr13:18862146..114342258 [GRCh38] Chr13:19436286..115107733 [GRCh37] Chr13:18334286..114125835 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:19837395-114327173)x3 | copy number gain | See cases [RCV000148126] | Chr13:19837395..114327173 [GRCh38] Chr13:20411535..115085141 [GRCh37] Chr13:19309535..114110750 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q31.1-34(chr13:82581008-114327173)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051380]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051380]|See cases [RCV000051380] | Chr13:82581008..114327173 [GRCh38] Chr13:83155143..115085141 [GRCh37] Chr13:82053144..114110750 [NCBI36] Chr13:13q31.1-34 |
pathogenic |
GRCh38/hg38 13q31.3-34(chr13:91366227-114327314)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051418]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051418]|See cases [RCV000051418] | Chr13:91366227..114327314 [GRCh38] Chr13:92018481..115085141 [GRCh37] Chr13:90816482..114110891 [NCBI36] Chr13:13q31.3-34 |
pathogenic |
GRCh38/hg38 13q32.3-33.1(chr13:99034367-101217397)x1 | copy number loss | Global developmental delay [RCV000051420]|See cases [RCV000051420] | Chr13:99034367..101217397 [GRCh38] Chr13:99686621..101869748 [GRCh37] Chr13:98484622..100667749 [NCBI36] Chr13:13q32.3-33.1 |
pathogenic |
GRCh38/hg38 13q32.3-34(chr13:101049614-114327314)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051421]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051421]|See cases [RCV000051421] | Chr13:101049614..114327314 [GRCh38] Chr13:101587036..115085141 [GRCh37] Chr13:100385037..114110891 [NCBI36] Chr13:13q32.3-34 |
pathogenic |
GRCh38/hg38 13q31.1-33.2(chr13:82032938-106082542)x3 | copy number gain | Seizure [RCV000051179]|See cases [RCV000051179] | Chr13:82032938..106082542 [GRCh38] Chr13:82607073..106734891 [GRCh37] Chr13:81505074..105532892 [NCBI36] Chr13:13q31.1-33.2 |
pathogenic |
GRCh38/hg38 13q32.3-33.1(chr13:101049614-101387801)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051925]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051925]|See cases [RCV000051925] | Chr13:101049614..101387801 [GRCh38] Chr13:101633906..102040152 [GRCh37] Chr13:100431907..100838153 [NCBI36] Chr13:13q32.3-33.1 |
uncertain significance |
GRCh38/hg38 13q32.3-33.1(chr13:101049614-101636191)x3 | copy number gain | Global developmental delay [RCV000052031]|See cases [RCV000052031] | Chr13:101049614..101636191 [GRCh38] Chr13:101615128..102288541 [GRCh37] Chr13:100413129..101086542 [NCBI36] Chr13:13q32.3-33.1 |
uncertain significance |
GRCh38/hg38 13q12.11-34(chr13:19837395-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053731]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053731]|See cases [RCV000053731] | Chr13:19837395..114327173 [GRCh38] Chr13:20411535..115085141 [GRCh37] Chr13:19309535..114110750 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18565048-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053719]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053719]|See cases [RCV000053719] | Chr13:18565048..114327173 [GRCh38] Chr13:19139188..115085141 [GRCh37] Chr13:18037188..114110750 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q11-34(chr13:18850545-114327173)x3 | copy number gain | Premature Birth [RCV000053723]|See cases [RCV000053723] | Chr13:18850545..114327173 [GRCh38] Chr13:19296527..115085141 [GRCh37] Chr13:18194527..114110750 [NCBI36] Chr13:13q11-34 |
pathogenic |
GRCh38/hg38 13q12.11-34(chr13:18946182-114304628)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053726]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053726]|See cases [RCV000053726] | Chr13:18946182..114304628 [GRCh38] Chr13:19520322..115070103 [GRCh37] Chr13:18418322..114088205 [NCBI36] Chr13:13q12.11-34 |
pathogenic |
GRCh38/hg38 13q31.3-33.1(chr13:93213623-101537104)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053790]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053790]|See cases [RCV000053790] | Chr13:93213623..101537104 [GRCh38] Chr13:93865876..102189455 [GRCh37] Chr13:92663877..100987456 [NCBI36] Chr13:13q31.3-33.1 |
pathogenic |
GRCh38/hg38 13q32.3-34(chr13:99472316-114293545)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053792]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053792]|See cases [RCV000053792] | Chr13:99472316..114293545 [GRCh38] Chr13:100124570..115059020 [GRCh37] Chr13:98922571..114077122 [NCBI36] Chr13:13q32.3-34 |
pathogenic |
GRCh38/hg38 13q32.3-34(chr13:100039860-114327173)x3 | copy number gain | Corpus callosum agenesis [RCV000053795]|See cases [RCV000053795] | Chr13:100039860..114327173 [GRCh38] Chr13:100692114..115085141 [GRCh37] Chr13:99490115..114110750 [NCBI36] Chr13:13q32.3-34 |
pathogenic |
GRCh38/hg38 13q13.2-34(chr13:33528097-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053759]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053759]|See cases [RCV000053759] | Chr13:33528097..114327173 [GRCh38] Chr13:34102234..115085141 [GRCh37] Chr13:33000234..114110750 [NCBI36] Chr13:13q13.2-34 |
pathogenic |
GRCh38/hg38 13q14.11-34(chr13:43219125-114327314)x3 | copy number gain | Polydactyly [RCV000053762]|See cases [RCV000053762] | Chr13:43219125..114327314 [GRCh38] Chr13:43793261..115085141 [GRCh37] Chr13:42691261..114110891 [NCBI36] Chr13:13q14.11-34 |
pathogenic |
GRCh38/hg38 13q14.11-34(chr13:44164751-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053764]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053764]|See cases [RCV000053764] | Chr13:44164751..114327173 [GRCh38] Chr13:44738887..115085141 [GRCh37] Chr13:43636887..114110750 [NCBI36] Chr13:13q14.11-34 |
pathogenic |
GRCh38/hg38 13q14.12-34(chr13:44733046-114327173)x3 | copy number gain | Nonsyndromic microcephaly [RCV000053767]|See cases [RCV000053767] | Chr13:44733046..114327173 [GRCh38] Chr13:45307182..115085141 [GRCh37] Chr13:44205182..114110750 [NCBI36] Chr13:13q14.12-34 |
pathogenic |
GRCh38/hg38 13q22.1-34(chr13:74345951-114327314)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053770]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053770]|See cases [RCV000053770] | Chr13:74345951..114327314 [GRCh38] Chr13:74920088..115085141 [GRCh37] Chr13:73818089..114110891 [NCBI36] Chr13:13q22.1-34 |
pathogenic |
GRCh38/hg38 13q31.1-34(chr13:80628584-114327173)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053772]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053772]|See cases [RCV000053772] | Chr13:80628584..114327173 [GRCh38] Chr13:81202719..115085141 [GRCh37] Chr13:80100720..114110750 [NCBI36] Chr13:13q31.1-34 |
pathogenic |
NM_052867.4(NALCN):c.4977C>T (p.Asp1659=) | single nucleotide variant | not specified [RCV000241776] | Chr13:101057985 [GRCh38] Chr13:101710337 [GRCh37] Chr13:13q32.3 |
likely benign |
NM_052867.4(NALCN):c.4977C>G (p.Asp1659Glu) | single nucleotide variant | not specified [RCV000595285] | Chr13:101057985 [GRCh38] Chr13:101710337 [GRCh37] Chr13:13q32.3 |
uncertain significance |
NM_052867.4(NALCN):c.5188G>A (p.Glu1730Lys) | single nucleotide variant | Congenital contractures of the limbs and face, hypotonia, and developmental delay [RCV000714747] | Chr13:101055324 [GRCh38] Chr13:101707676 [GRCh37] Chr13:13q32.3 |
uncertain significance |
NM_052867.4(NALCN):c.5209G>C (p.Asp1737His) | single nucleotide variant | Congenital contractures of the limbs and face, hypotonia, and developmental delay [RCV000789014] | Chr13:101055303 [GRCh38] Chr13:101707655 [GRCh37] Chr13:13q32.3 |
uncertain significance |
Database | Acc Id | Source(s) |
COSMIC | NALCN-AS1 | COSMIC |
Ensembl Genes | ENSG00000233009 | ENTREZGENE |
Ensembl Transcript | ENST00000457843 | ENTREZGENE |
GTEx | ENSG00000233009 | GTEx |
HGNC ID | HGNC:42743 | ENTREZGENE |
Human Proteome Map | NALCN-AS1 | Human Proteome Map |
NCBI Gene | NALCN-AS1 | ENTREZGENE |
RNAcentral | URS000075D232 | RNACentral |
UniGene | Hs.602949 | ENTREZGENE |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2012-08-21 | NALCN-AS1 | NALCN antisense RNA 1 | NALCN-AS1 | NALCN antisense RNA 1 (non-protein coding) | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on NALCN-AS1 | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 6484624 |
Created: | 2012-06-27 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.